SOURCE: YaFarm Technologies, Inc.

February 12, 2013 07:30 ET

ISCI Announces Global Physician Network

PITTSTON, ME--(Marketwire - Feb 12, 2013) -  YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today that The Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, has launched a global physician's network, to connect international patients to local physicians, and to link physicians to opportunities for education, training and collaboration in regenerative medicine.

ISCI has formed The International Stem Cell Practice (ISCP) to meet two very specific needs in the field of stem cell medicine: physician education and patient follow up. With the creation of this global network, the ISCI hopes to provide a highly scalable and versatile solution to serve the needs of both of these crucial audiences.

Working with a state-of-the art laboratory and a fully integrative medical facility in Cancun, Mexico, the ISCI and the ISCP will provide a venue for hands-on training in regenerative medicine as well as educational opportunities for physicians to exchange best practices and explore emerging trends in the field. The ISCP will also be hosting a series of regional meetings throughout the United States and Latin America to foster professional collaboration.

The main focus of the network, however, will be providing initial evaluation and long-term follow up for patients participating in the clinical studies of the ISCI. Members of the ISCP will work directly with the ISCI in providing medical oversight and care to patients participating in clinical studies.

"Long-term follow and data collection have always been one of the weakest elements of regenerative medicine," says David Audley, CEO of the ISCI. "This has been exacerbated by the fact that most patients must travel a great distance to get treatments, and it is next to impossible for the clinics to conduct thorough follow up." By connecting the patient to a local physician prior to their treatment, the ISCI assures not only that a thorough and independent evaluation of the patient is taken but also that it is logistically feasible for patients to visit a physician for post-treatment follow up and testing. "This network, with its connection between patients and local physicians, provides the final piece that has been missing in stem cell medicine," continues Mr. Audley. "This will allow us to finally collect the data needed to evidence outcomes and advance the field." 

About Integrative Stem Cell Institute (ISCI)
The Integrative Stem Cell Institute (ISCI) is a premier provider of point-of-care, stem cell-based therapies for patients from around the world. With a state of the art laboratory housed within the Hospital Galenia in Cancun, Mexico, the ISCI combines the most advanced scientific application of stem cells with second to none medical care within the structure of adaptive clinical trials to effectively track long term outcomes and assure patient safety. More information on the Integrative Stem Cell Institute is available at www.iscelli.com

SAFE HARBOR STATEMENT

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition, adequate financing, and other material risks. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance, or achievements to be materially different from the statements made herein.
Contact:

Contact Information

  • The Integrative Stem Cell Institute
    Contact:
    Miranda Abrahams
    Miranda@iscelli.com

    Investor Contact
    Atlanta Capital Partners, LLC
    David Kugelman
    (866) 692-6847
    info@atlcp.com